We are live on
!
Find out more
MRCM
M&R Capital Management Portfolio holdings
AUM
$454M
1-Year Est. Return
40.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.08%
1 Year Est. Return
+40.11%
3 Year Est. Return
+52.56%
5 Year Est. Return
+141.03%
10 Year Est. Return
+275.44%
AUM
$431M
AUM Growth
+$5K
(+0%)
Cap. Flow
+$12.3M
Cap. Flow
% of AUM
2.86%
Top 10 Holdings %
Top 10 Hldgs %
27.1%
Holding
573
New
14
Increased
91
Reduced
126
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$5.94M |
| 2 |
Synchrony
SYF
|
+$5.83M |
| 3 |
LSXMA
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
|
+$5.68M |
| 4 |
FCB
FCB Financial Holdings, Inc.
FCB
|
+$1.5M |
| 5 |
DuPont de Nemours
DD
|
+$580K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSX Corp
CSX
|
+$2.41M |
| 2 |
Norfolk Southern
NSC
|
+$1.33M |
| 3 |
Omega Healthcare
OHI
|
+$682K |
| 4 |
SHPG
Shire pic
SHPG
|
+$483K |
| 5 |
DHC
Diversified Healthcare Trust
DHC
|
+$483K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.99% |
| 2 | Miscellaneous | 14.4% |
| 3 | Communication Services | 12.47% |
| 4 | Technology | 11.55% |
| 5 | Healthcare | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LSXMA
26
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $5.76M | 1.34% |
194,163
+187,168
| +2,676% | +$5.68M |
|
|
27
Norfolk Southern
NSC
$78.3B
| $5.71M | 1.32% |
42,224
-9,274
| -18% | -$1.33M |
|
|
28
CSX Corp
CSX
$95B
| $5.32M | 1.23% |
286,311
-129,117
| -31% | -$2.41M |
|
|
29
Synchrony
SYF
$25.4B
| $5.26M | 1.22% |
+156,960
| New | +$5.83M |
|
30
Toronto Dominion Bank
TD
$199B
| $4.65M | 1.08% |
81,871
-257
| -0.3% | -$15K |
|
31
State Street
STT
$53.1B
| $4.47M | 1.04% |
44,794
-413
| -0.9% | -$43.3K |
|
32
Alphabet (Google) Class C
GOOG
$4.19T
| $4.33M | 1% |
84,160
+140
| +0.2% | +$7.73K |
|
33
Pfizer
PFE
$159B
| $4.27M | 0.99% |
126,843
-879
| -0.7% | -$30.2K |
|
34
CVS Health
CVS
$119B
| $3.96M | 0.92% |
63,592
+2,238
| +4% | +$161K |
|
35
Amazon
AMZN
$2.87T
| $3.72M | 0.86% |
51,440
-100
| -0.2% | -$7.15K |
|
36
Lloyds Banking Group
LYG
$85.7B
| $3.68M | 0.85% |
988,437
-22,082
| -2% | -$85.5K |
|
37
iShares Biotechnology ETF
IBB
$10.5B
| $3.53M | 0.82% |
32,678
-150
| -0.5% | -$16.6K |
|
38
BlackRock Credit Allocation Income Trust
BTZ
$946M
| $3.49M | 0.81% |
275,320
-8,350
| -3% | -$107K |
|
39
Meta Platforms (Facebook)
META
$1.47T
| $3.39M | 0.79% |
21,205
+2,913
| +16% | +$523K |
|
40
Ventas
VTR
$47.1B
| $3.31M | 0.77% |
66,139
-1,660
| -2% | -$87K |
|
|
INSI
41
DELISTED
Insight Select Income Fund
INSI
| $3.08M | 0.72% |
159,290
-2,100
| -1% | -$41.4K |
|
42
Procter & Gamble
PG
$334B
| $2.74M | 0.64% |
34,567
-2,347
| -6% | -$196K |
|
43
Colgate-Palmolive
CL
$72.3B
| $2.69M | 0.62% |
37,556
-1,220
| -3% | -$87.8K |
|
44
BP
BP
$109B
| $2.65M | 0.61% |
70,402
-3,820
| -5% | -$144K |
|
45
Union Pacific
UNP
$183B
| $2.62M | 0.61% |
19,455
-100
| -0.5% | -$13.5K |
|
46
Wells Fargo
WFC
$262B
| $2.6M | 0.6% |
49,816
-96
| -0.2% | -$5.7K |
|
47
AbbVie
ABBV
$451B
| $2.56M | 0.59% |
27,058
+665
| +3% | +$73.1K |
|
48
Chevron
CVX
$396B
| $2.41M | 0.56% |
21,110
+103
| +0.5% | +$12.3K |
|
49
Globe Life
GL
$13.3B
| $2.18M | 0.5% |
25,875
| – | – |
|
|
AGN
50
DELISTED
Allergan plc
AGN
| $2.16M | 0.5% |
12,791
-732
| -5% | -$123K |
|
Similar funds
EDRIA
SFP
AC
NIC
WCA
KC
SIGI
FPFS
M&R Capital Management's Q1 2018 Portfolio in Review
As of Q1 2018, M&R Capital Management held 573 positions worth $431M, up 0% from $431M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
M&R Capital Management's Q1 2018 filing shows 14 new, 91 increased, 126 reduced and 24 closed positions. Its largest new stake was Synchrony: 156,960 shares worth $5.26M. The largest sale was CSX Corp, an estimated $2.41M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Miscellaneous and Communication Services.
- M&R Capital Management's largest Q1 2018 buy was Synchrony: 156,960 shares worth $5.26M.
- M&R Capital Management added most to Applied Materials in Q1 2018, an estimated $5.94M increase.
- M&R Capital Management's biggest Q1 2018 reduction was CSX Corp, cutting an estimated $2.41M.
- M&R Capital Management fully exited Diversified Healthcare Trust in Q1 2018, selling an estimated $483K.
- M&R Capital Management's ten largest holdings make up 27% of its $431M portfolio in Q1 2018.
- M&R Capital Management opened 14 new positions and closed 24 in Q1 2018.
- M&R Capital Management's portfolio value rose 0% quarter-over-quarter to $431M.
Based on M&R Capital Management's 13F filing for Q1 2018, filed 11 May 2018.